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Introduction: Actinomyces are slow growing, non-spore forming, gram-positive, branching bacilli that thrive in
anaerobic and microareophilic conditions. Actinomyces are more commonly associated with oral and cervicofacial
infections. Hepatic involvement in infections of the abdomen (known as isolated hepatic actinomycosis) is rare,
accounting for only 5% of all cases of actinomycosis.
Case presentation: We present the case of a 75-year-old Caucasian woman with a 3-month history of night
sweats, fever, chills, abdominal bloating, anorexia, weight-loss, and early satiety. The patient was found to have
isolated hepatic actinomycosis infection after undergoing a laparotomy with a biopsy of the liver. The patient has
now recovered.
Conclusion: Isolated hepatic actinomycosis is a rare and often overlooked etiology for a liver mass. Given its
subacute presentation and nondescript symptomatology, physicians should be aware of this differential and the
potential pitfalls in diagnosis and management.
Introduction
Actinomyces are slow growing, non-spore forming,
gram-positive, branching bacilli that thrive in anaerobic
and microareophilic conditions. It is most commonly
associated with infection of the oral and cervicofacial
region. Abdominal actinomycosis is rare and its patho-
genesis is presumed to be hematogenous spread through
the portal vein from a mucosal injury or other abdom-
inal focus of infection. Most frequently affected is the
ileocecal region. Hepatic involvement has been reported
in 15% of those with abdominal infections, and repre-
sents 5% of all cases of actinomycosis [1]. Diagnosis is
often difficult because the predominant presenting
symptoms of fever, abdominal pain, and weight loss are
non-specific. Imaging is many times suspicious for neo-
plasm and positive cultures are notoriously difficult to
obtain, making the preoperative rate of diagnosis less
than 10%.
In this case report, we report a case of isolated hepatic
actinomycosis (IHA) occurring in a 75-year-old female
with no predisposing factors. Along with a review of the
literature, we will define the risk factors, clinical charac-
teristics, diagnostic methods, and treatment of this
infection.
Case presentation
A 75-year-old Caucasian woman of northern European
descent presented with a 3-month history of night
sweats, fevers (101-102°F nightly), chills, abdominal
bloating, anorexia with 60 lb weight loss and early sati-
ety. Her past medical history included hypertension,
hypothyroidism, gastroesophageal reflux disease, diverti-
culitis, polymyalgia rheumatica, and a laparoscopic cho-
lecystectomy in 1997. Current medications included
HydroDIURIL, Toprol XL, Diovan, Synthroid, Prilosec,
Plaquinil, and calcium supplementation. She denied any
abdominal pain, nausea, vomiting, diarrhea or constipa-
tion and was able to tolerate per os diet despite her
early satiety.
Physical examination revealed an elderly female who
did not appear to be in any acute distress. Vital signs:
temperature 100.7°F, pulse 54/bpm, respirations 20/min,
blood pressure 116/56 mm/Hg, oxygen saturation 98%
on room air. Abdominal exam revealed no palpable
hepatosplenomegaly, guarding or rebound with nor-
moactive bowel sounds. The rest of her exam was unre-
markable. Laboratory studies demonstrated a
leukocytosis of 12.8 10
3/mcL (4.0-10.0) and an absolute
neutrophil count of 10.9 10
3/mcL (1.7-1.6). Hemoglobin
level, hematocrit, platelet count and mean corpuscular
volume were 8.2 gm/dL (12.0-16.0), 23.9% (36-48), 341
10
3/mcL (140-450) and 85 FL (82-100) respectively. The
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oxaloacetic transaminase 17 IU/L (15-41), serum gluta-
mic pyruvic transaminase 15 IU/L (10-15), total biliru-
bin 0.6 mg/dL (0.0-2.0) and direct bilirubin 0.2 mg/dL
(0.0-0.8). Prothrombin time and international normal-
ized ratio were 14.9 sec (8.0-12.5) and 1.30 respectively.
There was an increase in alkaline phosphotase to 270
IU/L (27-120), tumor marker CA19-9 was 49.6 U/mL
(0-35) and alpha fetoprotein was elevated to a level of
7.3 IU/mL (< 5.5). Albumin was low at a level of 1.8
gm/dL (3.2-4.8) as was serum protein 5.0 gm/dL (6.1-
7.6). C-reactive protein, a marker of inflammation, was
elevated to a level of 10.8 mg/dL (< 0.5).
The patient underwent imaging with an ultrasound
of the liver and a CT of the abdomen. Both demon-
strated a lesion in the posterior right lobe of the liver
near the dome, measuring 6.9 × 7.4 cm, concerning
for abscess and malignancy (Figure 1). This area was
further characterized as not appearing fluid-like nor
did it contain gas that would have allowed for confir-
mation of abscess. The patient was started on cipro-
floxacin and flagyl for treatment of a potential abscess.
Neoplasia remained a concern at this point, as several
1 cm. nodules were visualized at the lung bases and
were concerning for metastatic disease. Gastroenterol-
ogy, as well as infectious disease consults were
obtained and the patient subsequently underwent liver
core biopsy and aspiration. These tests revealed nor-
mal hepatocytes and organizing abscess respectively
and both were negative for neoplasm. Unfortunately
the specimens recovered from the core biopsy and
aspiration were not stained for actinomycetes or sulfur
granules, which could have lead to earlier diagnosis.
Taking into consideration the patient’sp r e s e n t i n g
symptoms, multiple lung nodules and lack of positive
tissue diagnosis, malignancy could not be ruled out.
For definitive diagnosis the patient was to undergo a
video-assisted thoracic surgical (VATS) lung biopsy to
obtain frozen section for culture and histochemical
staining. The lung biopsy revealed fibrotic granulo-
mata and were non-diagnostic for malignancy. A gen-
eral surgeon then performed al a p a r o t o m yw i t hb i o p s y
of the liver. The liver specimen revealed neutrophilic
microabscesses (Figure 2) containing gram-positive,
filamentous, radially oriented bacteria in Brown and
Brenn stained sections, consistent with actinomycosis
(Figure 3). Characteristic sulfur granules were demon-
strated on frozen section as well (Figure 4). The
patient tolerated these procedures well and continued
on a course of intravenous clindamycin for 15 days
with transition to oral dosing lasting for a total of 6
months. She fully recovered and later imaging with
CT demonstrated complete resolution of the liver
abnormality.
Figure 1 CT scan of the liver demonstrating mass concerning
for abscess and tumor.
Figure 2 Grosse liver biopsy demonstrating multiple micro-
abscesses.
Figure 3 Tissue gram-stain demonstrating elongated, gram-
positive branching bacilli.
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Actinomyces is a rare cause of intra-abdominal infec-
tions. The etiology in the majority of cases involving the
liver, are thought to arise directly or hematogenically
from an intra-abdominal focus. In rare cases that involve
the liver, when a primary focus is not found, the disease
process is called primary or isolated hepatic actinomyco-
sis (IHA). There are 13 different species of actinomyco-
sis; 6 of which are associated with human disease
(israelii, naeslundii, bovis, odontolyticus, viscosus and
arachnia propionica). By far the most common human
pathogen encountered is Actinomyces israelii, giving rise
to chronic suppurative infections [2,3].
Risk factors include previous abdominal/pelvic surgery,
abdominal wall trauma, gastrointestinal foreign body,
gastrointestinal tract lesions and immunosupression [2].
Although the cause in the majority of cases is unknown
(80.7%), the abscess can appear after any disruption in
mucosal integrity [2]. Recent literature has cited an
increased risk for this infection with biliary and pancrea-
tic stent placement [4]. Association with the use of
intrauterine contraceptive devices (IUD) is well docu-
mented as a cause of cervical-pelvic infection that can
predispose to hematogenous spread [4,5]. Cases asso-
ciated with abdominal or pelvic procedures were
described in 17.5% of subjects reviewed in one study and
were followed by infection at <1 year [6]. This would
indicate that remote surgery (>1 yr previous) is not a risk
factor for development of IHA. In our patient she had
previously undergone a laparoscopic cholecystectomy
>15 years prior to presentation. It is thought that this did
n o tp l a yar o l ei nt h ed e v e l o p m e n to fh e ri n f e c t i o n .
Despite our case involving an elderly female, there is a
male predominance for hepatic actinomycotic abscess
(70-97%) with 30-50 years being the most common age
group [4,6]. One potential cause for concern in our
patient was her use of the immunosuppressive medica-
tion Plaquinil, which interferes with antigen presentation
to host immune cells. It is possible that the use of this
medication predisposed her to opportunistic infection.
Due to the cryptogenic nature of the disease, it takes
several weeks to months of symptoms to make the diag-
nosis with a range of 4 days to 18 months until presen-
tation [5]. The most common symptoms are non-
specific, including fever (83.3%), abdominal pain (74.5%)
and weight loss (50.9%) [7]. Laboratory examination
often demonstrates a leukocytosis (75%) with left shift
and elevation of alkaline phosphatase (83.3%), as seen in
our patient [2,6]. Several studies have also shown an
association with elevated CA19-9 levels. CA19-9 is a
carbohydrate epitope that is sialylated on the surface of
certain tumors. It is not organ specific and is clinically
used as a marker of pancreatic, hepatobiliary and gastric
malignancies [8]. This marker is often elevated in benign
disease states of the hepatobiliary system, renal failure,
pleural effusion, intestinal pneumonia and systemic
lupus erythematosus. With these types of benign condi-
tions the elevation of CA19-9 is often lower than malig-
nant conditions. At a level of 1000 U/ml the marker’s
positive predictive value approaches 100% [8]. In our
patient the CA19-9 level was 49.6 U/ml, which may
have been an indication that her presenting symptoms
were not secondary to a malignant process.
Because imaging studies frequently reveal single or
multiple lesions, actinomycosis is often misdiagnosed as
a primary or metastatic tumor. The most frequent
radiographical finding is a single hypodense mass/
abscess (68.4%) [7]. CT often demonstrates multilocu-
lated spaces occupying hypoattenuated lesions making a
differential diagnosis of echinococcosis, amoebiasis, mul-
tiple pyogenic abscess and cystic neoplasm [4]. MRI is
characterized by low-signal intensity on T1 and high-
signal intensity on T2 weighted images [9].
Definitive diagnosis is based on histochemical, macro-
scopic, and microscopic examination of surgical tissue
specimens, which reveal yellow sulfur granules and
basophilic filament aggregates respectively [2]. Cultures
can be positive but take up to 2 weeks to grow, second-
a r yt ol o wc o n c e n t r a t i o na n dt h ep r o p e n s i t yt og r o w
slowly. One study demonstrated that blood culture was
only positive in 2/13 (15.4%) cases reviewed [3,6].
Further complicating culture interpretation is that speci-
m e n sa r ec o m m o n l ym i x e dw i t ho t h e ro r g a n i s m s
(35.2%) [6]. Often the diagnosis requires surgical inter-
vention to obtain specimens adequate to demonstrate
the characteristic findings of sulfur granules and fila-
ment aggregates. Sharma et al. reviewed 35 cases in
which 29 (82.9%) required surgical intervention to
obtain specimens for diagnosis [6].
Figure 4 Frozen section demonstrating the characteristic sulfur
granules.
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therapeutically effective. The medical treatment regimen
for IHA is the administration of penicillin, tetracycline,
or clindamycin [2]. Duration of treatment is variable
with courses lasting from 3-6 months [4,5]. If antibiotics
do not lead to cure, surgical excision of the mass is
required for complete resolution as well as to rule out
neoplasm. A review of the literature by Wong et al.
showed that in one series, 28 of 53 cases were managed
with antibiotics alone and only two of these required
surgical intervention. They also reported no significant
difference in mortality between those that received anti-
biotics alone and those that had surgical intervention in
addition to antibiotics [10]. Recommended are follow up
examinations with imaging studies such as ultrasound
or CT to aid with duration of therapy.
Conclusion
In conclusion, IHA is a rare and often overlooked etiol-
ogy for a liver mass. Given its nonspecific presentation
and nondescript symptomatology, physicians should be
aware of this differential and the potential pitfalls in
diagnosis and management.
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